Not entirely true.
On wednesday next week PXS front the FDA's pulmonary-Allergy Drugs Advisory Committee to discuss the application. The committee will vote at the end of that meeting.
It is unusual for a positive recommendation to be knocked back by the FDA which then meets in March.
why pxs should get approval from fda!!, page-8
-
- There are more pages in this discussion • 11 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add SNT (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
2.8¢ |
Change
0.000(0.00%) |
Mkt cap ! $36.13M | |||
| Open | High | Low | Value | Volume |
| 2.9¢ | 3.0¢ | 2.8¢ | $145.4K | 5.129M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 10 | 1763138 | 2.7¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 2.8¢ | 235590 | 1 |
View Market Depth
| Last trade - 16.10pm 09/08/2024 (20 minute delay) ? |
| SNT (ASX) Chart |